SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060530
Filing Date
2024-05-15
Accepted
2024-05-15 16:30:56
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20240331.htm   iXBRL 10-Q 1872456
2 EX-31.1 bior-ex31_1.htm EX-31.1 16151
3 EX-31.2 bior-ex31_2.htm EX-31.2 16618
4 EX-32.1 bior-ex32_1.htm EX-32.1 14249
  Complete submission text file 0000950170-24-060530.txt   8975322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20240331.xsd EX-101.SCH 1579342
76 EXTRACTED XBRL INSTANCE DOCUMENT bior-20240331_htm.xml XML 1340005
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 24951521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)